4.8 Article

Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects

期刊

NATURE COMMUNICATIONS
卷 12, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-021-23187-9

关键词

-

资金

  1. Agence Nationale de la Recherche [ANR-16-CE92-0031, ANR-16-CE16-0015, ANR-19-CE17-0016]
  2. Fondation pour la recherche medicale (FRM) [DEQ20180339179]
  3. Axa Research Funds (rare diseases award 2019)
  4. Fondation Thierry Latran
  5. Radala Foundation
  6. MNDA [Dupuis/Apr16/852-791]
  7. ALSA [2235, 3209, 8075]
  8. Target ALS
  9. NINDS/NIH [R01-NS108769]
  10. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [390857198, 431995586, 443642953, 446067541]
  11. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under the SonderForschungsBereich (SFB) 1149/2 [251293561]
  12. Emmy Noether Programme
  13. Deutsche Gesellschaft fur Muskelkranke e.V.
  14. Graduate School for Systemic Neurosciences GSN-LMU
  15. Araminta Broch-Healey Endowed Chair in ALS
  16. ARSLA
  17. Region Grand Est (France)
  18. Agence Nationale de la Recherche (ANR) [ANR-16-CE92-0031] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Mutations in the RNA binding protein FUS are associated with ALS. Here the authors show that in FUS knock-in mice there is a progressive increase in neuronal activity in the frontal cortex which is associated with altered synaptic gene expression.
Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we show that cytoplasmic mislocalization of FUS drives behavioral abnormalities in knock-in mice, including locomotor hyperactivity and alterations in social interactions, in the absence of widespread neuronal loss. Mechanistically, we identified a progressive increase in neuronal activity in the frontal cortex of Fus knock-in mice in vivo, associated with altered synaptic gene expression. Synaptic ultrastructural and morphological defects were more pronounced in inhibitory than excitatory synapses and associated with increased synaptosomal levels of FUS and its RNA targets. Thus, cytoplasmic FUS triggers synaptic deficits, which is leading to increased neuronal activity in frontal cortex and causing related behavioral phenotypes. These results indicate that FUS mislocalization may trigger deleterious phenotypes beyond motor neuron impairment in ALS, likely relevant also for other neurodegenerative diseases characterized by FUS mislocalization. Mutations in the RNA binding protein FUS are associated with ALS. Here the authors show that in FUS knock-in mice there is a progressive increase in neuronal activity in the frontal cortex which is associated with altered synaptic gene expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing

Agostina Di Pizio, Letizia Marvaldi, Marie-Christine Birling, Nataliya Okladnikov, Luc Dupuis, Mike Fainzilber, Ida Rishal

Summary: Size homeostasis is essential for cells, especially large cells like neurons. A motor-dependent length-sensing mechanism involving reduction in microtubule motor levels was proposed and validated in Dync1h1Loa sensory neurons. In this study, a new mouse model with a conditional deletion allele of exons 24 and 25 in Dync1h1 was described. Heterozygous mice with reduced dynein expression exhibited accelerated growth, mild impairments in motor functions, and delayed recovery from peripheral nerve injury.

JOURNAL OF CELL SCIENCE (2023)

Article Clinical Neurology

Thrombolysis in central retinal artery occlusion: a retrospective observational study

Florian Philipp Raber, Florian Vincent Gmeiner, Jens Dreyhaupt, Armin Wolf, Albert Christian Ludolph, Jens Ulrich Werner, Jan Kassubek, Katharina Althaus

Summary: This study aimed to investigate the feasibility, efficacy, and safety of intravenous thrombolysis (IVT) in functionally blind patients with non-arteritic central retinal artery occlusion (NA-CRAO). The results showed that early IVT therapy within 4.5 hours of symptom onset might be a potential treatment option for NA-CRAO. MRI should be performed in all patients for optimized treatment and secondary stroke prevention.

JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

The metabolic axis of ALS: The role of body weight in disease pathogenesis

Luc Dupuis, Adriano Chio

MUSCLE & NERVE (2023)

Review Oncology

The CAM Model-Q&A with Experts

Dagmar Fischer, Georg Fluegen, Paul Garcia, Nassim Ghaffari-Tabrizi-Wizsy, Laura Gribaldo, Ruby Yun-Ju Huang, Volker Rasche, Domenico Ribatti, Xavier Rousset, Marta Texeira Pinto, Jean Viallet, Yan Wang, Regine Schneider-Stock

Summary: The chorioallantoic membrane (CAM) model is a valuable alternative in vivo test system for studying various aspects of cancer. It can be used to investigate angiogenesis, tumor growth, immune escape, metastasis, and drug resistance. The CAM model is easily accessible due to its location and is a simple, fast, and low-cost tool for studying tumor pathology and treatment responses in vivo.

CANCERS (2023)

Article Clinical Neurology

Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis

Matei Bolborea, Pauline Vercruysse, Tselmen Daria, Johanna C. Reiners, Najwa Ouali Alami, Simon J. Guillot, Stephane Dieterle, Jerome Sinniger, Jelena Scekic-Zahirovic, Amela Londo, Hippolyte Arcay, Marc-Antoine Goy, Claudia Nelson de Tapia, Dietmar R. Thal, Kazumoto Shibuya, Ryo Otani, Kimihito Arai, Satoshi Kuwabara, Albert C. Ludolph, Francesco Roselli, Deniz Yilmazer-Hanke, Luc Dupuis

Summary: Amyotrophic lateral sclerosis (ALS) is associated with impaired energy metabolism, including weight loss and decreased appetite. The neural mechanisms underlying metabolic impairment in ALS are not fully understood. This study found that hypothalamic atrophy occurs early in ALS patients. Loss of MCH-positive neurons was observed in mouse models of ALS, and supplementation with MCH led to weight gain and increased food intake in these mice. Moreover, pTDP-43 pathology and neurodegeneration were documented in the hypothalamus of ALS patients. These findings suggest that hypothalamic MCH loss contributes to the metabolic changes in ALS.

ACTA NEUROPATHOLOGICA (2023)

Review Clinical Neurology

Skeletal muscle in amyotrophic lateral sclerosis

Jeremy M. Shefner, Antonio Musaro, Shyuan T. Ngo, Christian Lunetta, Frederik J. Steyn, Richard Robitaille, Mamede De Carvalho, Seward Rutkove, Albert C. Ludolph, Luc Dupuis

Summary: Amyotrophic lateral sclerosis (ALS), a major motor neuron disease, has long been considered as primarily affecting motor neurons and neuromuscular junctions, with muscle changes being secondary. However, recent studies have shown that skeletal muscle dysfunction might contribute to muscle weakness, as well as the degeneration of neuromuscular junctions and motor neurons in ALS. This article explores the various potential roles of skeletal muscle in ALS pathophysiology and compares ALS to other motor neuron diseases, providing insights for future research and treatment.
Article Medicine, General & Internal

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers

Johannes Dorst, Patrick Weydt, David Brenner, Simon Witzel, Katharina Kandler, Andre Huss, Christine Herrmann, Maximilian Wiesenfarth, Antje Knehr, Kornelia Guenther, Kathrin Mueller, Jochen H. Weishaupt, Johannes Prudlo, Karin Forsberg, Peter M. Andersen, Angela Rosenbohm, Joachim Schuster, Francesco Roselli, Luc Dupuis, Benjamin Mayer, Hayrettin Tumani, Jan Kassubek, Albert C. Ludolph

Summary: The study found detectable metabolic alterations in presymptomatic ALS gene mutation carriers, suggesting the potential for early treatment and biomarker identification. These alterations precede changes in NfL levels, highlighting their importance in disease progression.

EBIOMEDICINE (2023)

Review Cell Biology

Current State and Future Directions in the Therapy of ALS

Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, Meret Herdick

Summary: Finding effective therapy for ALS is challenging, as the exact cause and pathological pathway are unknown. Current approved drugs only have moderate effects and no curative options are available. Recent breakthroughs in genetic research bring hope for improved treatment, but more efforts are needed.
Review Clinical Neurology

Nutritional and metabolic factors in amyotrophic lateral sclerosis

Albert Ludolph, Luc Dupuis, Edward Kasarskis, Frederik Steyn, Shyuan Ngo, Christopher McDermott

Summary: Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with non-motor symptoms. Nutritional status and metabolic balance have been found to contribute to faster disease progression and earlier death. Cellular changes, including mitochondrial dysfunction, are also shown to contribute to bioenergetic failure in ALS. Modifying energy balance in ALS shows potential as a treatment option and multiple clinical trials are underway.

NATURE REVIEWS NEUROLOGY (2023)

Article Neurosciences

Mutant FUS induces chromatin reorganization in the hippocampus and alters memory processes

Laura Tzeplaeff, Jonathan Seguin, Stephanie Le Gras, Salim Megat, Brigitte Cosquer, Damien Plassard, Stephane Dieterle, Isabel Paiva, Gina Picchiarelli, Charles Decraene, Rafael Alcala-Vida, Jean-Christophe Cassel, Karine Merienne, Luc Dupuis, Anne-Laurence Boutillier

Summary: Mislocalization of FUS protein in the cytoplasm is associated with ALS and FTD. However, the mechanisms linking FUS mislocalization to hippocampal function and memory formation are not fully understood. Studies in mice show that mutated FUS affects the epigenetic regulation of hippocampal neurons, leading to a disruption in chromatin organization and impaired spatial memory.

PROGRESS IN NEUROBIOLOGY (2023)

Article Engineering, Biomedical

Impact of cardiac and respiratory motion on the 3D accuracy of image-guided interventions on monoplane systems

Dagmar Bertsche, Patrick Metze, Leonhard-Moritz Schneider, Ina Vernikouskaya, Volker Rasche

Summary: The purpose of this study is to investigate the potential benefit of motion-compensation in IGS systems. Based on patient data, the accuracy of the IGI system was assessed and it was found that motion synchronization significantly increased the accuracy. The impact of cardiac and respiratory motion on accuracy and precision was also observed.

INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2023)

Article Clinical Neurology

Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping

Franz Marxreiter, Vera Lambrecht, Angelika Mennecke, Jannis Hanspach, Jelena Jukic, Martin Regensburger, Juergen Herrler, Alexander German, Jan Kassubek, Georg Groen, Hans-Peter Mueller, Frederik B. Laun, Arnd Doerfler, Juergen Winkler, Manuel A. Schmidt

Summary: Quantitative susceptibility mapping (QSM) on high-field MRI shows excellent diagnostic accuracy in the differential diagnosis of Parkinson's disease (PD) and multiple system atrophy (MSA). Particularly, putaminal susceptibility measures on ultra-high-field MRI can distinguish MSA patients from PD patients, allowing for an early and sensitive diagnosis of MSA.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2023)

Review Biochemistry & Molecular Biology

Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development

Anna Behler, Hans-Peter Mueller, Albert C. C. Ludolph, Jan Kassubek

Summary: Diffusion tensor imaging (DTI) can be used to visualize white matter alterations in patients with amyotrophic lateral sclerosis (ALS), and machine learning (ML) models based on DTI parameters offer new opportunities for ALS diagnosis and patient stratification. To capture the full range of neuropathological signatures, DTI can be combined with other modalities, such as T1w 3-D MRI, in ML models. Standardized DTI protocols and multi-center collaborations are needed to validate multimodal DTI biomarkers for ALS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study

Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson, Stacy Wu

Summary: Most patients with Parkinson's disease were able to optimize the dosage of sublingual apomorphine at home and find their optimal dosage.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2023)

Article Neuroimaging

Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study

Maximilian Wiesenfarth, Hans-Juergen Huppertz, Johannes Dorst, Dorothee Lule, Albert C. Ludolph, Hans-Peter Mueller, Jan Kassubek

Summary: This study explores the MRI characteristics of C9orf72-associated ALS and finds significant alterations in both white matter and gray matter in the early stages of the disease.

NEUROIMAGE-CLINICAL (2023)

暂无数据